Published in Ann Thorac Surg on February 01, 1986
Cardiac Surgery: In Vivo Titration of Protamine (Protamine) | NCT00684450
Lung inflammatory response syndrome after cardiac-operations and treatment of lornoxicam. J Thorac Dis (2014) 1.40
Effect of lornoxicam in lung inflammatory response syndrome after operations for cardiac surgery with cardiopulmonary bypass. J Thorac Dis (2014) 1.22
The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution. Ann Surg (1988) 1.05
Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (II): in vitro evaluation of efficacy and toxicity. AAPS PharmSci (2001) 0.90
Factors associated with excessive bleeding in cardiopulmonary bypass patients: a nested case-control study. J Cardiothorac Surg (2007) 0.88
Genetic susceptibility to inflammatory injury and various adverse outcomes. J Extra Corpor Technol (2009) 0.78
Complement activation during cardiac and thoracic vascular operations. Tex Heart Inst J (1987) 0.75
Methylene Blue to Treat Protamine-induced Anaphylaxis Reactions. An Experimental Study in Pigs. Braz J Cardiovasc Surg (2016) 0.75
Effects of cardiopulmonary bypass on lung nuclear factor-kappa B activity, cytokine release, and pulmonary function in dogs. Iran J Basic Med Sci (2015) 0.75
Acute respiratory distress syndrome after cardiac surgery. J Thorac Dis (2016) 0.75
Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med (2001) 11.56
Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med (1999) 7.59
Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum (1986) 6.11
Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med (1990) 4.70
Replacement of the aortic root in patients with Marfan's syndrome. N Engl J Med (1999) 4.17
The successful implementation of pharmaceutical practice guidelines. Analysis of associated outcomes and cost savings. SWiPE Group. Systematic Withdrawal of Perioperative Expenses. Anesthesiology (1997) 3.92
Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med (1993) 3.90
Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg (2001) 3.61
Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA (2000) 3.24
Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1978) 3.08
Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. RESTORE group. Reconstructive Endoventricular Surgery, returning Torsion Original Radius Elliptical Shape to the LV. J Am Coll Cardiol (2001) 2.93
Treatment of infective endocarditis: a 10-year comparative analysis. Circulation (1978) 2.90
Midazolam: pharmacology and uses. Anesthesiology (1985) 2.89
The effect of neuromuscular blockade on mask ventilation. Anaesthesia (2011) 2.88
Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med (1981) 2.63
Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: A propensity analysis. JAMA (2001) 2.56
Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg (1999) 2.53
Valuing the work performed by anesthesiology residents and the financial impact on teaching hospitals in the United States of a reduced anesthesia residency program size. Anesth Analg (1998) 2.48
Worldwide esophageal cancer collaboration. Dis Esophagus (2009) 2.41
Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci U S A (1985) 2.38
Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol (1999) 2.36
Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg (1983) 2.29
Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg (1998) 2.25
Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation? J Thorac Cardiovasc Surg (2001) 2.22
Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N Engl J Med (1983) 2.18
Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort. Ann Intern Med (2000) 2.16
Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg (1998) 2.14
Clinical outcomes after the arterial switch operation for transposition. Patient, support, procedural, and institutional risk factors. Congenital Heart Surgeons Society. Circulation (1992) 2.08
Outcome after a "perfect" Fontan operation. Circulation (1990) 2.06
The Importance of the Level of the Lesion in the Prognosis and Treatment of Carcinoma of the Rectum and Low Sigmoid Colon. Ann Surg (1949) 2.04
Central nervous system complications of cardiac surgery. Br J Anaesth (2000) 2.03
Radiating leg pain in the older patient. Hosp Pract (Off Ed) (1991) 2.03
Life expectancy without surgery in tetralogy of Fallot. Am J Cardiol (1978) 2.01
Legionella birminghamensis sp. nov. isolated from a cardiac transplant recipient. J Clin Microbiol (1987) 1.94
Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg (2001) 1.93
Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg (2001) 1.92
Cerebral blood flow and metabolism during cardiopulmonary bypass. Anesth Analg (1993) 1.89
Injury to a patent left internal thoracic artery graft at coronary reoperation. Ann Thorac Surg (1999) 1.88
Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i). Circ Res (2000) 1.88
Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. Ann Thorac Surg (2000) 1.87
Results of repair of ventricular septal defect. J Thorac Cardiovasc Surg (1966) 1.86
Complete bundle branch block as an independent predictor of all-cause mortality: report of 7,073 patients referred for nuclear exercise testing. Am J Med (2001) 1.84
Surgery for acute dissection of ascending aorta. Should the arch be included? J Thorac Cardiovasc Surg (1992) 1.83
Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease. N Engl J Med (1983) 1.79
Anatomic observations on complete form of persistent common atrioventricular canal with special reference to atrioventricular valves. Mayo Clin Proc (1966) 1.78
Ventricular septal defects: a surgical viewpoint. J Am Coll Cardiol (1989) 1.74
Early and late results after intracardiac repair of Tetralogy of Fallot. 5-Year review of 337 patients. Ann Surg (1965) 1.68
Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg (1996) 1.64
A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med (1989) 1.64
Prosthetic valve endocarditis. Circulation (1984) 1.60
Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography. Circulation (2001) 1.58
Outflow obstruction after the arterial switch operation: a multiinstitutional study. Congenital Heart Surgeons Society. J Thorac Cardiovasc Surg (1997) 1.58
Current prognosis of ischemic mitral regurgitation. Implications for future management. Circulation (1988) 1.57
Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action. Anesth Analg (2007) 1.57
A modified method for chemotaxis under agarose. J Immunol Methods (1979) 1.55
Hypoplastic left heart syndrome: experience with palliative surgery. Am J Cardiol (1980) 1.55
Results of partial left ventriculectomy for dilated cardiomyopathy: hemodynamic, clinical and echocardiographic observations. J Am Coll Cardiol (2000) 1.55
Pretransplantation risk factors for death after heart transplantation: the Henri Mondor experience. J Heart Lung Transplant (1998) 1.53
An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. SPI Research Group. Anesth Analg (1994) 1.51
Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg (2001) 1.50
Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Ann Thorac Surg (1997) 1.48
Replacement of diseased aortic valves with homografts. Ann Surg (1969) 1.47
Death and other time-related events after valve replacement. Circulation (1985) 1.47
Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant (1998) 1.46
Cardiac repair in anatomically corrected malposition of the great arteries. Circulation (1973) 1.46
Biocompatibility of hemodialysis membranes: evaluation in an ovine model. J Lab Clin Med (1993) 1.46
Reoperation on prosthetic heart values. Patient-specific estimates of in-hospital events. J Thorac Cardiovasc Surg (1995) 1.44
epsilon-Aminocaproic acid plasma levels during cardiopulmonary bypass. Anesth Analg (1997) 1.44
The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery. Eur Heart J (1998) 1.44
Outcome probabilities and life history after surgical mitral commissurotomy: implications for balloon commissurotomy. J Am Coll Cardiol (1991) 1.44
Using an anesthesia information management system as a cost containment tool. Description and validation. Anesthesiology (1997) 1.43
Routine primary repair vs two-stage repair of tetralogy of Fallot. Circulation (1979) 1.43
Factors influencing early and late outcome of the arterial switch operation for transposition of the great arteries. J Thorac Cardiovasc Surg (1995) 1.43
Epidural anesthesia and analgesia: implications for perioperative coagulability. Anesth Analg (1991) 1.42
Outcomes in neonatal pulmonary atresia with intact ventricular septum. A multiinstitutional study. J Thorac Cardiovasc Surg (1993) 1.42
Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol Immunol (1980) 1.41
Continuous murmurs in tetralogy of Fallot and pulmonary atresia with ventricular septal defect. Am J Cardiol (1966) 1.41
Cerebral blood flow values during cardiopulmonary bypass: relatively absolute or absolutely relative? Ann Thorac Surg (1995) 1.40
Intermediate septal accessory pathways: electrocardiographic characteristics, electrophysiologic observations and their surgical implications. J Am Coll Cardiol (1991) 1.40
Esophagectomy with gastric reconstruction for achalasia. J Thorac Cardiovasc Surg (1999) 1.40
Determinants of heart-lung transplantation outcomes: results of a consensus survey. Ann Thorac Surg (1993) 1.39
The DeMeester paper on carcinoma of the esophagus . J Thorac Cardiovasc Surg (1990) 1.39